Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

512results about How to "Safe for clinical use" patented technology

Traditional Chinese medicine composition for treating chronic pharyngitis or tonsillitis and preparation method thereof

The invention discloses a traditional Chinese medicine composition for treating chronic pharyngitis or tonsillitis and a preparation method thereof. The traditional Chinese medicine composition for treating chronic pharyngitis or tonsillitis comprises 20 to 40 parts of radix sophorae tonkinensis, 20 to 40 parts of fragrant solomonseal rhizome, 15 to 35 parts of root of straight ladybell, 15 to 35 parts of lasiosphaera seu calvatia, 15 to 25 parts of hyacinth bean, 12 to 25 parts of great burdock achene, 12 to 25 parts of mulberry leaf, 12 to 25 parts of blackberry lily rhizome, 12 to 25 parts of platycodon root, 4 to 15 parts of mint, 4 to 15 parts of isatis root, 3 to 12 parts of dandelion, 3 to 12 parts of Tokyo violet herb, 4 to 15 parts of honey-suckle bud and flower, 3 to 12 parts of weeping forsythia capsule, 3 to 12 parts of common andrographis herb, 2 to 10 parts of common bletilla rubber and 1 to 8 parts of liquorice root. The traditional Chinese medicine composition has effects of clearing heat and removing toxins, moistening lung and relieving a cough, and relieving sore throat and dissipating binds, has clear effects of treating chronic pharyngitis and tonsillitis, realizes simultaneous treatment of principal and subordinate symptoms, is safe in clinical application, and has no toxic and side effect.
Owner:黄文珍

Chinese medicine composition for treating haemorrhoids

The invention provides a Chinese medicine composition for treating haemorrhoids. The prescription is consisted of fumigating-washing medicine and oral medicine, wherein the fumigating-washing medicine is consisted of Saposhnikovia divaricata, schizonepeta, talc, dandelion, phellodendron, peach seed, angelica dahuricae, glabrous Greenbrier Rhizome, cimicifuga, pagodatree flowers and pagodatree pod; the oral medicine is consisted of dark plum fruit, Sophora flavescens, Blackberrykiky Rhizome, Chinese gall, scorpion, Scutellaria baicalensis, clam, Cacumen biotae, Chinese torreya seed, water spinach, rock tripe, Agrimonia pilosa, bitter orange, white muscardine silkworm and Fructus Cannabis. The invention provides a Chinese medicine composition for treating haemorrhoids, wherein the compatibility of each drug can play the effects of removing pathogenic heat from blood, hemostasis and convergence and blood circulation. In the invention, the Chinese medicine composition can address both symptoms and root causes to all kinds of symptoms, and the curative effect is exactly reliable and true proved by clinical curative effect observation. The Chinese medicine preparation provided by the invention is non-toxic, harmless and safe and reliable, does not have an adverse effect after administration and is safe in clinical use.
Owner:朱惠芬

Traditional Chinese medicine lotion for treating hemorrhoids

The invention provides traditional Chinese medicine lotion for treating hemorrhoids. The traditional Chinese medicine lotion for treating the hemorrhoid is prepared from the following traditional Chinese medicine materials: gallnut, sophora flower, cortex lycii radices, alum, Momordica cochinchinensis, folium artemisiae argyi, loranthus parasiticus, pepper, plantain seed, radix angelicae, Ailanthus altissima Swingle, fructus aurantii, honeysuckle, cimicifugae foetidae, smoked plum, radix sophorae flavescentis, blackberry lily, fructus cannabis, Scutellaria baicalensis, Ammannia baccifera, hedgehog hide, rheum officinale, hairyvein agrimony, pagoda tree fruit, Cacumen biotae, peach kernel, herba portulacae, cinnabar, Ligusticum wallichii, bezoar, safflower carthamus, leech, Polygonum cuspidatum, borneol, duckweed and mongolian oak leaf. The traditional Chinese medicine lotion for treating the hemorrhoids has effects of removing heat to cool blood, stopping bleeding and astringing and promoting blood circulation to remove blood stasis by the compatibility of all the traditional Chinese medicines. Symptoms and root causes of the hemorrhoids with various symptoms can be treated by the traditional Chinese medicine composition. Proved by observation, a clinical effect is exact, reliable and real. The traditional Chinese medicine lotion provided by the invention is non-toxic and harmless, is safe and reliable and is safe in clinical use, and no adverse reaction is generated after fumigation and washing.
Owner:韩兆东

Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof

The invention relates to a traditional Chinese medicine composition, particularly a traditional Chinese medicine composition for treating rheumatoid arthritis and a preparation method thereof. The traditional Chinese medicine composition for treating rheumatoid arthritis is prepared from glabrous greenbrier rhizome, radix clematidis, homalomena rhizoma, schizophragma integrifolium, club moss, spatholobus stem, orienavine, futokadsura stem, Trachelospermum jasminoides, ephedra, folium artemisiae argyi, black-tail snake, frankincense, myrrh, angelica, notopterygium root, heracleum hemsleyanum michaux, radix cyathulae, angelica, radix sileris, cassia twig, papaya, kudzu root, ant, radix astragali, rhizoma atractylodis, cherokee rose, licorice and ground beetle. By properly compounding the multiple medicines, the mutually synergic or resisting effects are utilized to lower or eliminate the toxic and side effects of the medicines, reduce the untoward reaction and enhance the curative effect; the traditional Chinese medicine composition is safe for clinical application, does not stimulate the viscera when being taken orally, is convenient to make and take, ensures the cleanliness of the medicines, is easy for storage, has the advantages of obvious curative effect, many absorbable effective components and favorable drug effect taking, and can treat both the symptoms and root causes; and the total effective rate is up to 96%.
Owner:韩世昌

Traditional Chinese medicine composition for treating seborrheic dermatitis and acne and preparation method thereof

The invention discloses a traditional Chinese medicine composition for treating seborrheic dermatitis and acne and a preparation method thereof. The traditional Chinese medicine composition comprises 16 to 35 parts of honeysuckle, 16 to 35 parts of Chinese honeylocust spine, 16 to 35 parts of divaricate saposhnikovia root, 12 to 28 parts of dahurian angelica root, 12 to 28 parts of tendrilleaf fritillary bulb, 12 to 28 parts of garden sorrel, 10 to 25 parts of semiaquilegia adoxoides, 10 to 25 parts of akebia stem, 10 to 25 parts of dandelion, 10 to 25 parts of Tokyo violet herb, 8 to 15 parts of spanishneedles herb, 8 to 15 parts of weeping forsythia capsule, 8 to 15 parts of Chinese wolfberry root-bark, 6 to 12 parts of sarcandra, 6 to 12 parts of elephants-foot, 5 to 10 parts of poria cocos, 5 to 10 parts of paniculate swallowwort root, 5 to 10 parts of Chinese clematis root, 5 to 10 parts of great burdock achene, 5 to 10 parts of kudzuvine root, 5 to 10 parts of wilford granesbill herb, 4 to 8 parts of snakegourd root, 4 to 8 parts of pangolin scales, 4 to 8 parts of dried orange peel, 3 to 8 parts of haw and 2 to 6 parts of licorice. The traditional Chinese medicine composition has obvious effects of treating seborrheic dermatitis and acne and is safe in clinical application.
Owner:黄文珍

Traditional Chinese medicine composite for treating mammitis and lobular hyperplasia of mammary gland and preparation method thereof

The invention discloses a traditional Chinese medicine composite for treating mammitis and lobular hyperplasia of mammary gland and a preparation method thereof. The traditional Chinese medicine composite comprises the following components in parts by weight: 3-10 parts of radix bupleuri, 12-25 parts of fructus toosendan, 10-20 parts of radix clematidis, 6-12 parts of curcuma zedoary, 2-8 parts of oyster, 10-20 parts of garden balsam, 12-25 parts of pericarpium citri reticulatae viride, 4-12 parts of cornu cervi degelatinatum, 10-20 parts of dandelion, 12-25 parts of vegetable sponge and 1-6 parts of liquorice. The traditional Chinese medicine composite can be prepared into any one clinically acceptable oral medicine preparation according to a traditional Chinese preparation method. The traditional Chinese medicine composite treats both principal and secondary aspects of the mammitis and the lobular hyperplasia of mammary gland. Proved by clinical effect observation, the traditional Chinese medicine composite takes the obvious curative effects on the mammitis and the lobular hyperplasia of mammary gland. The traditional Chinese medicine composite has no toxin or harm, is safe and reliable, cannot generate adverse reaction after being orally taken and is safe in clinical application.
Owner:黄文珍

Complex traditional Chinese medicine preparation for treating upper respiratory tract infection and preparation method thereof

The invention relates to a complex traditional Chinese medicine preparation for treating upper respiratory tract infection and a preparation method thereof. The complex traditional Chinese medicine preparation comprises the following raw materials: 10-25 parts of picria felterrae lour, 5-15 parts of herba sarcandrae, 5-15 parts of senecio, 5-13 parts of pubescent holly root and 1-5 parts of liquorice. The preparation method comprises the following steps: pulverizing a proper amount of picria felterrae lour into fine powders; adding water into residual picria felterrae lour, the herba sarcandrae, the senecio, and the like and extracting to obtain extracts; adding alcohol into the extracts to carry out alcohol deposition, filtration and concentration to form thick paste; uniformly mixing, drying and pulverizing the thick paste and the picria felterrae lour fine powder to form fine powders; and adding a proper number of auxiliary materials and uniformly mixing to prepare particles or adding general preparation auxiliary materials to prepare general solid oral administration preparation. According to clinical observation for many years, the traditional Chinese medicine preparation benzyrin tablet has the obvious treating effects on a patient with upper respiratory tract infection diseases, such as upper respiratory tract inflammation, bronchitis, rhinitis, pharyngolaryngitis, tonsillitis, and the like.
Owner:南宁市言如其保健食品有限公司

Chinese medicinal ointment for treating intervertebral disc hyperosteogeny and preparation method thereof

The invention discloses a Chinese medicinal ointment, in particular a Chinese medicinal ointment for treating intervertebral disc hyperosteogeny and a preparation method thereof. The Chinese medicinal ointment for treating the intervertebral disc hyperosteogeny is characterized by being prepared from the following components: Chinese angelica root, notopterygium, pubescent angelica root, clematis root, earthworm, suberect spatholobus stem, insects, white mustard seed, garter snake, drynaria, Chinese honeylocust spine, garden balsam stem, medicinal cyathula root, cassia twig, papaya, eucommia bark, divaricate saposhnikovia root, ephedra, acanthopanax bark, Chinese taxillus twig, pangolin scales, frankincense, myrrh, dragon's blood, musk and plum borneol. The Chinese medicinal ointment is specially used for treating the intervertebral disc hyperosteogeny, and by using the Chinese medicinal ointment, the concentration of the medicament applied into local tissues is significantly higher than the blood concentration, so the Chinese medicinal ointment is brought into full play, the local curative effect is obviously superior to internal treatment, and the Chinese medicinal ointment takes effect rapidly, has wide adaptation diseases, is safe to use, and has less toxic or side effect. 690 cases using the Chinese medicinal ointment for treatment show that the total effective rate reaches 96 percent.
Owner:NANTONG KANGSHENG MEDICAL EQUIP

Chimeric antigen receptor targeting CD22 and application for chimeric antigen receptor

InactiveCN111320703AHas persistent antitumor activityPersistent antitumor activityMammal material medical ingredientsImmunoglobulinsProtein moleculesAntigen binding
The invention discloses a chimeric antigen receptor targeting CD22 and an application for the chimeric antigen receptor. The chimeric antigen receptor has a sequence selected from one of the followingtwo structures: a first structure, which comprises a CD22 antigen binding domain and a constant domain of a T cell receptor (TCR); and a second structure, which comprises a transmembrane protein signal peptide, a CD22 antigen binding structural domain, a CD8 protein molecule hinge region, a transmembrane region, a 4-1BB costimulatory structural domain and a CD3<zeta> intracellular signal transduction structural domain which are sequentially connected in series. Compared with a traditional CD28, 4-1BB costimulatory structural domain, the chimeric antigen receptor provided by the invention shows more persistent anti-tumor activity, can be combined with CD19 chimeric antigen receptor T cells for sequential application, improves the coverage rate of CART cells on tumor cells, or is applied totreatment of leukemia negative recurrence by being combined with the CD19 chimeric antigen receptor T cells, and has good application prospect in treatment of blood and lymphatic system malignant tumors.
Owner:北京双赢科创生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products